Pro-apoptotic effect of nonsteroidal anti-inflammatory drugs on synovial fibroblasts

References

• American College of Rheumatology Subcommittee on Rheuma-toid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum. 2002;46: 328–46.
   PubMed Web of Science ®Google Scholar
• A research group of the Japanese Ministry of Health, Labour and Welfare. Guidelines for treatment of rheumatoid arthritis (in Japanese). In: Ochi T, Yamamoto K, Ryu J, editors. Diagnostic manual and guideline for the treatment of rheumatoid arthritis based on EBM. Tokyo: Japan Rheumatism Foundation; 2004. p. 51–104.
   Google Scholar
• Kawai S. Current drug therapy for rheumatoid arthritis. J Orthop Sci. 2003;8:259–63.
   PubMedGoogle Scholar
• Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature. 1998;396:77–80.
   Google Scholar
• Goldring SR. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford). 2003;42\(Suppl 2):ii11–6.
   Google Scholar
• Karouzakis E, Neidhart M, Gay RE, Gay S. Molecular and cel-lular basis of rheumatoid joint destruction. Immunol Lett. 2006;106:8–13.
   PubMed Web of Science ®Google Scholar
• Baier A, Meineckel I, Gay S, Pap T. Apoptosis in rheumatoid arthritis. Curr Opin Rheumatol. 2003;15:274–9.
   PubMed Web of Science ®Google Scholar
• Ospelt C, Neidhart M, Gay RE, Gay S. Synovial activation in rheumatoid arthritis. Front Biosci. 2004;9:2323–34.
   PubMed Web of Science ®Google Scholar
• Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 1995;83: 803–12.
   PubMed Web of Science ®Google Scholar
• Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit pro-duction of monocyte inflammatory cytokines. Nature. 1998;391:82–6.
   Google Scholar
• Kawahito Y, Kondo M, Tsubouchi Y, Hashiramoto A, Bishop-Bailey D, Inoue K, et al. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest. 2000;106: 189–97.
   Google Scholar
• Fujisawa K, Asahara H, Okamoto K, Aono H, Hasunuma T, Kobata T, et al. Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice. J Clin Invest. 1996; 98:271–8.
   PubMed Web of Science ®Google Scholar
• Peng SL. Fas (CD95)-related apoptosis and rheumatoid arthritis. Rheumatology (Oxford). 2006;45:26–30.
   PubMed Web of Science ®Google Scholar
• Lacey D, Sampey A, Mitchell R, Bucala R, Santos L, Leech M, et al. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum. 2003;48:103–9.
   PubMed Web of Science ®Google Scholar
• Yamazaki R, Kusunoki N, Matsuzaki T, Hashimoto S, Kawai S. Nonsteroidal anti-inflammatory drugs induce apoptosis in asso-ciation with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells. J Pharmacol Exp Ther. 2002;302:18–25.
   Google Scholar
• Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflam-matory drugs. J Biol Chem. 1997;272:3406–10.
   Google Scholar
• Yamazaki R, Kusunoki N, Matsuzaki T, Hashimoto S, Kawai S. Aspirin and sodium salicylate inhibit proliferation and induce apoptosis in rheumatoid synovial cells. J Pharm Pharmacol. 2002;54:1675–9.
   Google Scholar
• Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 1994;265:956–9.
   PubMed Web of Science ®Google Scholar
• Tsai JC, Jain M, Hsieh CM, Lee WS, Yoshizumi M, Patterson C, et al. Induction of apoptosis by pynolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J Biol Chem. 1996;271:3667–70.
   PubMed Web of Science ®Google Scholar
• Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, et al. Inhibition of NF-kappa B/Rel induces apoptosis of murine B cells. EMBO J. 1996;15:4682–90.
   PubMed Web of Science ®Google Scholar
• Ozaki K, Takeda H, Iwahashi H, Kitano S, Hanazawa S. NF-kappa B inhibitors stimulate apoptosis of rabbit mature osteo-clasts and inhibit bone resorption by these cells. FEBS Lett. 1997;410:297–300.
   Google Scholar
• Kismet K, Akay MT, Abbasoglu 0, Ercan A. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Cancer Detect Prey. 2004;28: 127–42.
   Google Scholar
• Kusunoki N, Yamazaki R, Kawai S. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors. Arthritis Rheum. 2002;46: 3159–67.
   Google Scholar
• Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991;325:1593–6.
   Google Scholar
• de Groot DJ, de Vries EG, Groen HJ, de Jong S. Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic. Crit Rev Oncol Hematol. 2007;61:52–69.
   PubMed Web of Science ®Google Scholar
• Yamazaki R, Kusunoki N, Matsuzaki T, Hashimoto S, Kawai S. Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocar-cinoma cells. FEBS Lett. 2002;531: 278–84.
   Google Scholar
• Chun KS, Akunda JK, Langenbach R. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prosta-glandin E2 receptors, EP2 and EP4. Cancer Res. 2007;67: 2015–21.
   Google Scholar
• Inoue A, Muranaka S, Fujita H, Kanno T, Tamai H, Utsumi K. Molecular mechanism of diclofenac-induced apoptosis of pro-myelocytic leukemia: dependency on reactive oxygen species, Akt, Bid, cytochrome and caspase pathway. Free Radic Biol Med. 2004;37:1290–9.
   PubMed Web of Science ®Google Scholar
• Derouet M, Thomas L, Moulding DA, Akgul C, Cross A, Moots RJ, et al. Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mc1-1. J Immunol. 2006;176:957–65.
   PubMedGoogle Scholar
• Cheng J, Imanishi H, Liu W, Nakamura H, Morisaki T, Higashino K, et al. Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines. Cancer Sci. 2004;95:666–73.
   PubMed Web of Science ®Google Scholar
• Baoping Y, Guoyong H, Jieping Y, Zongxue R, Hesheng L. Cyclooxygenase-2 inhibitor nimesulide suppresses telomerase activity by blocking Akt/PKB activation in gastric cancer cell line. Dig Dis Sci. 2004;49: 948–53.
   Google Scholar
• Honjo S, Osaki M, Ardyanto TD, Hiramatsu T, Maeta N, Ito H. COX-2 inhibitor, N5398, enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carci-noma cell lines. DNA Cell Biol. 2005;24:141–7.
   PubMed Web of Science ®Google Scholar
• Johnson AJ, Hsu AL, Lin HP, Song X, Chen CS. The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2±-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks. Biochem J. 2002;366: 831–7.
   Google Scholar
• Shishodia S, Koul D, Aggarwal BB. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activa-tion through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J Immunol. 2004;173: 2011–22.
   Google Scholar
• McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, FitzGerald GA. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selec-tive inhibitor of COX-2. Proc Natl Acad Sci USA. 1999;96: 272–7.
   PubMed Web of Science ®Google Scholar
• Kusunoki N, Ito T, Sakurai N, Suguro T, Handa H, Kawai S. A novel celecoxib derivative potently induces apoptosis of human synovial fibroblasts. J Pharmacol Exp Ther. 2005;314:796–803.
   PubMed Web of Science ®Google Scholar
• Kusunoki N, Ito T, Sakurai N, Handa H, Kawai S. A celecoxib derivative potently inhibits proliferation of colon adenocarcinoma cells by induction of apoptosis. Anticancer Res. 2006;26:3229–36.
   Google Scholar
• Lee HC, Park IC, Park MJ, An S, Woo SH, Jin HO, et al. Sul-indac and its metabolites inhibit invasion of glioblastoma cells via down-regulation of Akt/PKB and MMP-2. J Cell Biochem. 2005;94:597–610.
   PubMedGoogle Scholar
• Bae MA, Pie JE, Song BJ. Acetaminophen induces apoptosis of C6 glioma cells by activating the c-Jun NH(2)-terminal protein kinase-related cell death pathway. Mol Pharmacol. 2001;60: 847–56.
   Google Scholar
• Planagumà A, Clària J, Miguel R, López-Parra M, Titos E, Masferrer JL, et al. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. FASEB J. 2005;19:1120–2.
   PubMed Web of Science ®Google Scholar
• Lee A, Frischer J, Serur A, Huang J, Bae JO, Kornfield ZN, et al. Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling. Cancer Res. 2006;66:4378–84.
   PubMed Web of Science ®Google Scholar
• Taketa K, Matsumura T, Yano M, Ishii N, Senokuchi T, Motoshima H, et al. Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor- {alpha} (PPAR{ alpha}) and PPAR{ gamma} through MAPK-dependent COX-2 expression in macrophages. J Biol Chem. 2008;283:9852–62.
   PubMedGoogle Scholar
• Hollingshead HE, Borland MG, Billin AN, Willson TM, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-acti-vated receptor-beta/delta (PPARbetaidelta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms. Carcinogenesis. 2008;29: 169–76.
   PubMedGoogle Scholar
• Kato M, Nishida S, Kitasato H, Sakata N, Kawai S. Cyclooxy-genase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol. 2001;53: 1679–85.
   Google Scholar
• Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointes-tinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA. 1999;96:7563–8.
   PubMed Web of Science ®Google Scholar